Frontiers in Pharmacology (Dec 2022)

The effect of the cyclic GMP-AMP synthase-stimulator of interferon genes signaling pathway on organ inflammatory injury and fibrosis

  • Yuliang Liu,
  • Yuliang Liu,
  • Yuliang Liu,
  • Yihui Li,
  • Yihui Li,
  • Yihui Li,
  • Li Xue,
  • Li Xue,
  • Li Xue,
  • Jie Xiao,
  • Jie Xiao,
  • Jie Xiao,
  • Pengyong Li,
  • Pengyong Li,
  • Pengyong Li,
  • Wanlin Xue,
  • Wanlin Xue,
  • Wanlin Xue,
  • Chen Li,
  • Chen Li,
  • Chen Li,
  • Haipeng Guo,
  • Haipeng Guo,
  • Haipeng Guo,
  • Yuguo Chen,
  • Yuguo Chen,
  • Yuguo Chen

DOI
https://doi.org/10.3389/fphar.2022.1033982
Journal volume & issue
Vol. 13

Abstract

Read online

The cyclic GMP-AMP synthase-stimulator of interferon genes signal transduction pathway is critical in innate immunity, infection, and inflammation. In response to pathogenic microbial infections and other conditions, cyclic GMP-AMP synthase (cGAS) recognizes abnormal DNA and initiates a downstream type I interferon response. This paper reviews the pathogenic mechanisms of stimulator of interferon genes (STING) in different organs, including changes in fibrosis-related biomarkers, intending to systematically investigate the effect of the cyclic GMP-AMP synthase-stimulator of interferon genes signal transduction in inflammation and fibrosis processes. The effects of stimulator of interferon genes in related auto-inflammatory and neurodegenerative diseases are described in this article, in addition to the application of stimulator of interferon genes-related drugs in treating fibrosis.

Keywords